Your browser doesn't support javascript.
loading
Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers.
Karu, Naama; Kindt, Alida; Lamont, Lieke; van Gammeren, Adriaan J; Ermens, Anton A M; Harms, Amy C; Portengen, Lutzen; Vermeulen, Roel C H; Dik, Willem A; Langerak, Anton W; van der Velden, Vincent H J; Hankemeier, Thomas.
Affiliation
  • Karu N; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
  • Kindt A; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
  • Lamont L; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
  • van Gammeren AJ; Department of Clinical Chemistry and Hematology, Amphia Hospital, 4818 CK Breda, The Netherlands.
  • Ermens AAM; Department of Clinical Chemistry and Hematology, Amphia Hospital, 4818 CK Breda, The Netherlands.
  • Harms AC; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
  • Portengen L; Department of Population Health Sciences, Institute for Risk Assessment Sciences, University Utrecht, 3584 CK Utrecht, The Netherlands.
  • Vermeulen RCH; Department of Population Health Sciences, Institute for Risk Assessment Sciences, University Utrecht, 3584 CK Utrecht, The Netherlands.
  • Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Langerak AW; Laboratory Medical Immunology, Department of Immunology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Hankemeier T; Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
Metabolites ; 12(7)2022 Jul 04.
Article in En | MEDLINE | ID: mdl-35888743

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Metabolites Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Metabolites Year: 2022 Document type: Article Affiliation country: Country of publication: